Enumeral Biomedica Stock Price, News & Analysis (OTCMKTS:ENUM)

$0.0027 0.00 (0.00 %)
(As of 12/14/2017 04:00 PM ET)
Previous Close$0.00
Today's Range$0.00 - $0.00
52-Week RangeN/A
Volume1.00 million shs
Average Volume305,045 shs
Market Capitalization$390,000.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.03

About Enumeral Biomedica (OTCMKTS:ENUM)

Enumeral Biomedical Holdings, Inc., a biopharmaceutical company, engages in discovering and developing antibody immunotherapies that help the immune system fight cancer and other diseases. It is developing two antagonist PD-1 antibodies, such as ENUM 388D4 and ENUM 244C8 for use in treating cancer. The company is also developing antibody drug candidates for various immunomodulatory protein targets, including TIM-3, CD39, and TIGIT. Enumeral Biomedical Holdings, Inc. has collaboration agreements with Merck Sharp & Dohme Corp.; and The University of Texas MD Anderson Cancer Center, as well as a research contract with the National Cancer Institute. Enumeral Biomedical Holdings, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.

Receive ENUM News and Ratings via Email

Sign-up to receive the latest news and ratings for ENUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ENUM
CUSIPN/A
Phone617-945-9146

Debt

Debt-to-Equity RatioN/A
Current Ratio0.31%
Quick Ratio0.31%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.45 million
Price / Sales0.14
Cash FlowN/A
Price / CashN/A
Book Value$0.03 per share
Price / Book0.09

Profitability

Trailing EPS($0.17)
Net Income$-11,850,000.00
Net Margins-1,945.52%
Return on Equity-1,157.75%
Return on Assets-497.92%

Miscellaneous

Employees10
Outstanding Shares128,410,000

Enumeral Biomedica (OTCMKTS:ENUM) Frequently Asked Questions

What is Enumeral Biomedica's stock symbol?

Enumeral Biomedica trades on the OTCMKTS under the ticker symbol "ENUM."

How were Enumeral Biomedica's earnings last quarter?

Enumeral Biomedica (OTCMKTS:ENUM) issued its quarterly earnings results on Monday, August, 14th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.19 million for the quarter. Enumeral Biomedica had a negative net margin of 1,945.52% and a negative return on equity of 1,157.75%. View Enumeral Biomedica's Earnings History.

Who are some of Enumeral Biomedica's key competitors?

How do I buy Enumeral Biomedica stock?

Shares of Enumeral Biomedica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Enumeral Biomedica's stock price today?

One share of Enumeral Biomedica stock can currently be purchased for approximately $0.00.

How big of a company is Enumeral Biomedica?

Enumeral Biomedica has a market capitalization of $390,000.00 and generates $2.45 million in revenue each year. The company earns $-11,850,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis. Enumeral Biomedica employs 10 workers across the globe.

How can I contact Enumeral Biomedica?

Enumeral Biomedica's mailing address is 200 CambridgePark Drive Suite 2000, Cambridge MA, 02140. The company can be reached via phone at 617-945-9146 or via email at [email protected]


MarketBeat Community Rating for Enumeral Biomedica (ENUM)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  34
MarketBeat's community ratings are surveys of what our community members think about Enumeral Biomedica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Enumeral Biomedica (OTCMKTS:ENUM) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Enumeral Biomedica (OTCMKTS:ENUM) Earnings History and Estimates Chart

Earnings by Quarter for Enumeral Biomedica (OTCMKTS:ENUM)

Enumeral Biomedica (OTCMKTS ENUM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2017Q2 2017($0.02)$0.19 millionViewN/AView Earnings Details
5/22/2017Q1 2017($0.02)$0.02 millionViewN/AView Earnings Details
8/12/2015Q2 2015($0.04)($0.04)$0.10 million$0.38 millionViewN/AView Earnings Details
3/19/2015Q4 2014($0.05)$0.06$0.09 million$0.04 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Enumeral Biomedica (OTCMKTS:ENUM) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Enumeral Biomedica (OTCMKTS:ENUM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Enumeral Biomedica (OTCMKTS ENUM)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Enumeral Biomedica (OTCMKTS ENUM) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Enumeral Biomedica (OTCMKTS:ENUM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Enumeral Biomedica (OTCMKTS ENUM) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.